Infectious diseases don't wait.
Neither do we

We protect children's futures from pregnancy through
adolescence with equitable science

Get to know us


Penta is an international independent scientific network dedicated to maternal and child health. Our work is the result of a passionate collaboration between healthcare professionals and researchers in 124 clinical sites and 26 cohorts across 27 countries around the world.

Through our studies and partnerships, we develop and deliver world-class research and training in paediatric infectious diseases to improve the lives of women and children, wherever they live.

Are you interested joining the Penta ID Network? Complete this form to apply.

Meet the 2026 Penta Brighter Future Award (BFA) winners!

This prestigious biennial award recognises visionary leaders dedicated to dismantling health inequities in maternal and child infectious diseases, specifically targeting HIV, tuberculosis (TB), vaccine access and the fortification of fragile health systems.

Penta Strategy 2025-2029: building on progress, driving strategic impact

Building on the results of our previous strategy, Penta’s 2025-2029 Strategic Plan focuses on accelerating scientific impact through high-quality research and strategic partnerships, especially in regions with the greatest need.

Penta advocates for equitable access to healthcare across all activities and strives to engage with affected and at-risk communities to maximise impact.

 

Current Penta studies around the World



Always expanding

Penta continues to grow, bringing together healthcare professionals, researchers and scientists worldwide to address a wide range of healthcare issues.
0

Members

0

Countries

0

Years of activity

0

Ongoing studies and projects

Previous

Latest News

Next

Strengthening paediatric HIV care in Zimbabwe: THRIVE AHD training workshop in Kadoma

21 Sep, 2026

In April 2026, healthcare workers from across Kadoma District gathered for the THRIVE Workshop on the Management of Children with Advanced HIV Disease (AHD) in Primary Care, strengthening the knowledge…
Read More

New evidence from NeoIPC study supports the case for unit-wide infection prevention in Europe’s neonatal units

21 Sep, 2026

New findings from the NeoIPC Colonisation Surveillance study, published in JAMA Network Open, show that the more babies on a neonatal unit are already carrying resistant bacteria,
Read More

TEAM-COACH Project concludes with strong results and ambitious plans for international expansion

16 Sep, 2026

The EU4Health co-funded TEAM-COACH project has concluded after three years of work to strengthen Antimicrobial Stewardship (AMS) and Infection Prevention and Control (IPC) practices in paediatric healthcare settings across Southern…
Read More

Making older antibiotics work safely for children with sepsis. An interview with the SNIP-AFRICA team

09 Sep, 2026

Around the world, more bacterial infections are growing resistant to standard antibiotics, making them harder to treat. Antimicrobial resistance is especially dangerous for critically ill newborns, infants and young children,
Read More

Children must not be left behind in Bundibugyo virus disease research, Penta experts warn

01 Sep, 2026

Penta ID Network members and Scientific Steering Committee chairs Ali Judd and Pablo Rojo have co-authored a commentary in The Lancet Child & Adolescent Health calling for urgent action to…
Read More

Keep up to date with the latest Penta news

Sign up to receive our monthly Penta Newsletter filled with the latest news on our studies, projects and people